About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
218
By Phase
PHASE2: 2
By Status
COMPLETED: 4WITHDRAWN: 2RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05851547Collaborator
Dose Escalation For INtraprostatic LEsions
PHASE2Recruiting
54 participants
Started: Nov 23, 2023 · Completed: Jun 30, 2028
NCT04566458Collaborator
RWD Study in HER2+ mBC Patients in Third-Line Therapy
N/ACompleted
63 participants
Started: Oct 1, 2020 · Completed: May 30, 2021
NCT02429518Lead Sponsor
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
N/ACompleted
42 participants
Started: Dec 31, 2015 · Completed: Mar 6, 2018
NCT02427308Lead Sponsor
Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
N/AWithdrawn
Started: Jul 31, 2015 · Completed: Mar 28, 2025
NCT02429505Lead Sponsor
Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
N/AWithdrawn
Started: Jul 31, 2015 · Completed: Mar 31, 2020
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...